Nanoparticles of various architectures—liposomes, dendrimers, polymeric micelles—can be surface-modified (e.g., with monoclonal antibodies, peptides, transferrin) to enhance tumor targeting and reduce off-target distribution [89]. This evidence concerns the gene TF and neoplasm.